3
Announcements
Trials
Browse
Landscape
Status
Completed
2
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
1
Breast Diseases
1
Interventions
Paclitaxel
83
Fulvestrant
64
Trastuzumab
62
Letrozole
62
pembrolizumab
54
Carboplatin
51
Cyclophosphamide
49
pertuzumab
46
palbociclib
45
Anastrozole
41
Capecitabine
33
Tamoxifen
30
Magnetic Resonance Spectroscopy
29
exemestane
28
Radiotherapy
28
Doxorubicin
28
olaparib
26
Docetaxel
26
ribociclib
25
abemaciclib
25
Specimen Handling
25
Epirubicin
20
130-nm albumin-bound paclitaxel
20
trastuzumab deruxtecan
19
Taxes
19
Gemcitabine
19
durvalumab
18
Surveys and Questionnaires
18
eribulin
17
Alpelisib
17
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Blood Pressure
×
Breast
×
Clear all
NCT05006196
2026-05-20
IMOGEN
Perspectum
Active not recruiting
1,030 enrolled